Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MF”

225 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 225 results

Large-scale testing (Phase 3)Study completedNCT00149201
What this trial is testing

5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Gastric CancerNeoplasm Metastasis
Japan Clinical Oncology Group 160
Testing effectiveness (Phase 2)Looking for participantsNCT06887803
What this trial is testing

Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK Inhibitors

Who this might be right for
Myelofibrosis (MF)
iOnctura 26
Testing effectiveness (Phase 2)Study completedNCT00946270
What this trial is testing

Pomalidomide for Myelofibrosis Patients

Who this might be right for
Polycythemia VeraThrombocythemia
M.D. Anderson Cancer Center 70
Testing effectiveness (Phase 2)Study completedNCT01633372
What this trial is testing

An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis

Who this might be right for
MPN (Myeloproliferative Neoplasms)
Incyte Corporation 87
Early research (Phase 1)Not Yet RecruitingNCT07529951
What this trial is testing

Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers

Who this might be right for
Polycythemia Vera (PV)Myelofibrosis (MF)
Eilean Therapeutics 60
Not applicableWithdrawnNCT02469974
What this trial is testing

Ruxolitinib in Combination With Autotransplant

Who this might be right for
MyelofibrosisMF
Marina Kremyanskaya
Testing effectiveness (Phase 2)UnknownNCT04640532
What this trial is testing

KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF

Who this might be right for
MyelofibrosisPost-PV MFPost-ET Myelofibrosis+1 more
Kartos Therapeutics, Inc. 116
Large-scale testing (Phase 3)Looking for participantsNCT07317700
What this trial is testing

A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis

Who this might be right for
MF
Chengdu Zenitar Biomedical Technology Co., Ltd 105
Large-scale testing (Phase 3)Study completedNCT04353817
What this trial is testing

A Study Evaluating Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis and F/MF Genotypes

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 121
Testing effectiveness (Phase 2)Temporarily pausedNCT01211691
What this trial is testing

Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)

Who this might be right for
Myelodysplastic Syndrome (MDS)Myelofibrosis (MF)
Humanigen, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT00569660
What this trial is testing

Ph II Study of Azacitidine in Myelofibrosis

Who this might be right for
Myelofibrosis
M.D. Anderson Cancer Center 34
Early research (Phase 1)Looking for participantsNCT07195916
What this trial is testing

Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Solid TumorsHematologic Malignancies
Incyte Corporation 280
Large-scale testing (Phase 3)Study completedNCT03952039
What this trial is testing

An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib

Who this might be right for
Primary MyelofibrosisPost-Polycythemia VeraMyelofibrosis
Celgene 202
Not applicableApproved For MarketingNCT04058210
What this trial is testing

VX-445/TEZ/IVA Expanded Access Program for Cystic Fibrosis (CF) Patients Heterozygous for F508del Mutation and a Minimal Function Mutation (F/MF Genotypes)

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated
Early research (Phase 1)Active Not RecruitingNCT04041050
What this trial is testing

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

Who this might be right for
Myeloproliferative Neoplasm
AbbVie 85
Large-scale testing (Phase 3)Study completedNCT04472598
What this trial is testing

Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

Who this might be right for
Myelofibrosis (MF)
AbbVie 252
Testing effectiveness (Phase 2)Looking for participantsNCT06327100
What this trial is testing

Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)

Who this might be right for
Primary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-Essential Thrombocytosis Myelofibrosis
M.D. Anderson Cancer Center 33
Testing effectiveness (Phase 2)WithdrawnNCT01615874
What this trial is testing

Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)

Who this might be right for
Asthma
Organon and Co
Not applicableStudy completedNCT01652066
What this trial is testing

Effect of a Mixture of Probiotics on the Antigen Specific Antibody Response in a Influenza Vaccination Model of Healthy Adults

Who this might be right for
Enhancement of Protective Antibody Response After Probiotic Consumption
Merck Medication Familiale 430
Testing effectiveness (Phase 2)UnknownNCT01298934
What this trial is testing

LBH589 (Panobinostat) for the Treatment of Myelofibrosis

Who this might be right for
Primary MyelofibrosisPolycythemia Vera, Post-Polycythemic Myelofibrosis PhasePost-Essential Thrombocythemia Related Myelofibrosis
Ronald Hoffman 22
Load More Results